Cart
sales@molnova.com
4-Chloro-3-(trifluoromethyl)phenyl isocyanate
CAS No. 327-78-6
4-Chloro-3-(trifluoromethyl)phenyl isocyanate( —— )
Catalog No. M37066 CAS No. 327-78-6
4-Chloro-3-(trifluoromethyl)phenyl isocyanate is a biochemical reagent that can be produced by a series of reactions between o-chlorobenzotrifluoride and acetic anhydride.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 27 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Chloro-3-(trifluoromethyl)phenyl isocyanate
-
NoteResearch use only, not for human use.
-
Brief Description4-Chloro-3-(trifluoromethyl)phenyl isocyanate is a biochemical reagent that can be produced by a series of reactions between o-chlorobenzotrifluoride and acetic anhydride.
-
Description4-Chloro-3-(trifluoromethyl)phenyl isocyanate is a biochemical reagent that can be produced by a series of reactions between o-chlorobenzotrifluoride and acetic anhydride.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number327-78-6
-
Formula Weight221.56
-
Molecular FormulaC8H3ClF3NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)(F)c1cc(ccc1Cl)N=C=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Adrenomedullin (16-3...
Adrenomedullin (16-31), human is amino acid residues 16-31 fragment of human adrenomedullin (hADM).
-
Substance P (1-7) 2T...
Substance P (1-7) 2TFA(68060-49-1(free base)) is the major bioactive metabolite formed after proteolytic degradation of the tachykinin substance P (SP)with anti-inflammatory anti-nociceptive and anti-hyperalgesic effects.
-
KRA-533
KRA-533 is a potent KRAS agonist. KRA-533 binds to the GTP/GDP binding pocket in the KRAS protein to prevent GTP cleavage, resulting in the accumulation of constitutively active GTP-bound KRAS that triggers both apoptotic and autophagic cell death pathways in cancer cells.
